Development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice.
Laboratory mice play a tremendous role in biomedical research in studies on immunology, infection, cancer and therapy. In the course of standardization of mice used in animal experiments, health monitoring constitutes an important instrument towards microbiological standardization. Infections with m...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5663422?pdf=render |
id |
doaj-8604de17b20a49e7a2027fc3350d8835 |
---|---|
record_format |
Article |
spelling |
doaj-8604de17b20a49e7a2027fc3350d88352020-11-25T01:30:48ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-011210e018717410.1371/journal.pone.0187174Development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice.Katja SchmidtJulia ButtPetra MauterKlaus VogelAndrea Erles-KemnaMichael PawlitaWerner NicklasLaboratory mice play a tremendous role in biomedical research in studies on immunology, infection, cancer and therapy. In the course of standardization of mice used in animal experiments, health monitoring constitutes an important instrument towards microbiological standardization. Infections with murine astroviruses (MuAstV) were only recently discovered and are, therefore, still relatively unknown in laboratory animal science. In rodent health monitoring viral infections within a population are commonly assessed in terms of specific antibodies by serological testing, as active infection and excretion of virus is often temporary and can easily be missed. So far only ongoing infections with astroviruses can be detected by PCR. The objective of this work was the development of a sensitive and specific MuAstV multiplex serological assay with a high-throughput capability to be used in routine testing of laboratory mice. Four different MuAstV proteins were recombinantly expressed and used as antigens. The best reacting antigen, the capsid spike protein VP27, was selected and tested with a panel of 400 sera of mice from units with a known MuAstV status. Assay sensitivity and specificity resulted in 98.5% and 100%, respectively, compared to RT-PCR results. Eventually this assay was used to test 5529 serum samples in total, during routine diagnostics at the German Cancer Research Center (DKFZ) in Heidelberg between 2015 and 2017. High sero-prevalence rates of up to 98% were detected in units with open cages indicating that the virus is highly infectious and circulates within these populations virtually infecting all animals regardless of the mouse strain. In addition, data collected from 312 mice purchased from commercial breeders and from 661 mice from 58 research institutes in 15 countries worldwide allowed the conclusion that MuAstV is widespread in contemporary laboratory mouse populations.http://europepmc.org/articles/PMC5663422?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Katja Schmidt Julia Butt Petra Mauter Klaus Vogel Andrea Erles-Kemna Michael Pawlita Werner Nicklas |
spellingShingle |
Katja Schmidt Julia Butt Petra Mauter Klaus Vogel Andrea Erles-Kemna Michael Pawlita Werner Nicklas Development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice. PLoS ONE |
author_facet |
Katja Schmidt Julia Butt Petra Mauter Klaus Vogel Andrea Erles-Kemna Michael Pawlita Werner Nicklas |
author_sort |
Katja Schmidt |
title |
Development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice. |
title_short |
Development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice. |
title_full |
Development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice. |
title_fullStr |
Development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice. |
title_full_unstemmed |
Development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice. |
title_sort |
development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2017-01-01 |
description |
Laboratory mice play a tremendous role in biomedical research in studies on immunology, infection, cancer and therapy. In the course of standardization of mice used in animal experiments, health monitoring constitutes an important instrument towards microbiological standardization. Infections with murine astroviruses (MuAstV) were only recently discovered and are, therefore, still relatively unknown in laboratory animal science. In rodent health monitoring viral infections within a population are commonly assessed in terms of specific antibodies by serological testing, as active infection and excretion of virus is often temporary and can easily be missed. So far only ongoing infections with astroviruses can be detected by PCR. The objective of this work was the development of a sensitive and specific MuAstV multiplex serological assay with a high-throughput capability to be used in routine testing of laboratory mice. Four different MuAstV proteins were recombinantly expressed and used as antigens. The best reacting antigen, the capsid spike protein VP27, was selected and tested with a panel of 400 sera of mice from units with a known MuAstV status. Assay sensitivity and specificity resulted in 98.5% and 100%, respectively, compared to RT-PCR results. Eventually this assay was used to test 5529 serum samples in total, during routine diagnostics at the German Cancer Research Center (DKFZ) in Heidelberg between 2015 and 2017. High sero-prevalence rates of up to 98% were detected in units with open cages indicating that the virus is highly infectious and circulates within these populations virtually infecting all animals regardless of the mouse strain. In addition, data collected from 312 mice purchased from commercial breeders and from 661 mice from 58 research institutes in 15 countries worldwide allowed the conclusion that MuAstV is widespread in contemporary laboratory mouse populations. |
url |
http://europepmc.org/articles/PMC5663422?pdf=render |
work_keys_str_mv |
AT katjaschmidt developmentofamultiplexserologicalassayrevealsaworldwidedistributionofmurineastrovirusinfectionsinlaboratorymice AT juliabutt developmentofamultiplexserologicalassayrevealsaworldwidedistributionofmurineastrovirusinfectionsinlaboratorymice AT petramauter developmentofamultiplexserologicalassayrevealsaworldwidedistributionofmurineastrovirusinfectionsinlaboratorymice AT klausvogel developmentofamultiplexserologicalassayrevealsaworldwidedistributionofmurineastrovirusinfectionsinlaboratorymice AT andreaerleskemna developmentofamultiplexserologicalassayrevealsaworldwidedistributionofmurineastrovirusinfectionsinlaboratorymice AT michaelpawlita developmentofamultiplexserologicalassayrevealsaworldwidedistributionofmurineastrovirusinfectionsinlaboratorymice AT wernernicklas developmentofamultiplexserologicalassayrevealsaworldwidedistributionofmurineastrovirusinfectionsinlaboratorymice |
_version_ |
1725089754644480000 |